Distribution and Antibiotic Resistance Characteristics of Bacteria Isolated from Blood Culture in a Teaching Hospital in Vietnam During 2014–2021

References

• Antimicrobial Resistance Collaborators. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. Lancet. 2022;399(10325):629–655. doi:10.1016/S0140-6736(21)02724-0
   PubMed Web of Science ®Google Scholar
• Deku JG, Dakorah MP, Lokpo SY, et al. The epidemiology of bloodstream infections and antimicrobial susceptibility patterns: a nine-year retrospective study at St. Dominic hospital, Akwatia, Ghana. J Trop Med. 2019;2019:6750864. doi:10.1155/2019/6750864
   PubMed Web of Science ®Google Scholar
• Fisman D, Patrozou E, Carmeli Y, et al. Geographical variability in the likelihood of bloodstream infections due to gram-negative bacteria: correlation with proximity to the equator and health care expenditure. PLoS One. 2014;9(12):e114548. doi:10.1371/journal.pone.0114548
   PubMed Web of Science ®Google Scholar
• Hu F, Guo Y, Yang Y, et al. Resistance reported from China antimicrobial surveillance network (CHINET) in 2018. Eur J Clin Microbiol Infect Dis. 2019;38(12):2275–2281. doi:10.1007/s10096-019-03673-1
   PubMed Web of Science ®Google Scholar
• Kim D, Yoon EJ, Hong JS, et al. Major bloodstream infection-causing bacterial pathogens and their antimicrobial resistance in South Korea, 2017-2019: Phase I report from kor-GLASS. Front Microbiol. 2021;12:799084. doi:10.3389/fmicb.2021.799084
   PubMedGoogle Scholar
• Schöneweck F, Schmitz RPH, Rissner F, et al. The epidemiology of bloodstream infections and antimicrobial susceptibility patterns in Thuringia, Germany: a five-year prospective, state-wide surveillance study (AlertsNet). Antimicrob Resist Infect Control. 2021;10(1):132. doi:10.1186/s13756-021-00997-6
   PubMed Web of Science ®Google Scholar
• Robledo J, Maldonado N, Robledo C, et al. Changes in antimicrobial resistance and etiology of blood culture isolates: results of a decade (2010-2019) of surveillance in a northern region of Colombia. Infect Drug Resist. 2022;15:6067–6079. doi:10.2147/IDR.S375206
   PubMed Web of Science ®Google Scholar
• Licata F, Quirino A, Pepe D, Matera G, Bianco A. Antimicrobial resistance in pathogens isolated from blood cultures: a two-year multicenter hospital surveillance study in Italy. Antibiotics. 2020;10(1). doi:10.3390/antibiotics10010010
   Google Scholar
• Tack B, Phoba MF, Van Puyvelde S, et al. Salmonella typhi from blood cultures in the Democratic Republic of the Congo: a 10-year surveillance. Clin Infect Dis. 2019;68(Suppl 2):S130–7. doi:10.1093/cid/ciy1116
   PubMed Web of Science ®Google Scholar
• Leber AL. Clinical Microbiology Procedures Handbook. 4th ed. Washington, DC, DC: American Society for Microbiology; 2016.
   Google Scholar
• Garcia LS. Clinical Microbiology Procedures Handbook. 3rd ed. Washington, DC, DC: American Society for Microbiology; 2010.
   Google Scholar
• Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing. 24th ed. Wayne, PA: Clinical and Laboratory Standards Institute, M100-S24; 2014.
   Google Scholar
• Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing. 31st ed. Wayne, PA: Clinical and Laboratory Standards Institute, M100-S31; 2021.
   Google Scholar
• International Organization for Standardization. ISO 15189-Medical Laboratories - Requirements for Quality and Competence. 3rd ed. Switzerland: International Organization for Standardization; 2012.
   Google Scholar
• Magiorakos AP, Srinivasan A, Carey RB, et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect. 2012;18(3):268–281. doi:10.1111/j.1469-0691.2011.03570.x
   PubMed Web of Science ®Google Scholar
• Skogberg K, Lyytikäinen O, Ollgren J, Nuorti JP, Ruutu P. Population-based burden of bloodstream infections in Finland. Clin Microbiol Infect. 2012;18(6):E170–6. doi:10.1111/j.1469-0691.2012.03845.x
   PubMed Web of Science ®Google Scholar
• Mehl A, Åsvold BO, Lydersen S, et al. Burden of bloodstream infection in an area of Mid-Norway 2002-2013: a prospective population-based observational study. BMC Infect Dis. 2017;17(1):205. doi:10.1186/s12879-017-2291-2
   PubMedGoogle Scholar
• Vu TVD, Do TTN, Rydell U, et al. Antimicrobial susceptibility testing and antibiotic consumption results from 16 hospitals in Viet Nam: the VINARES project 2012-2013. J Glob Antimicrob Resist. 2019;18:269–278. doi:10.1016/j.jgar.2019.06.002
   PubMedGoogle Scholar
• Vu TVD, Choisy M, Do TTN, et al. Antimicrobial susceptibility testing results from 13 hospitals in Viet Nam: VINARES 2016-2017. Antimicrob Resist Infect Control. 2021;10(1):78. doi:10.1186/s13756-021-00937-4
   PubMed Web of Science ®Google Scholar
• Hu F, Zhu D, Wang F, Wang M. Current status and trends of antibacterial resistance in China. Clin Infect Dis. 2018;67(Suppl 2):S128-S34:S128–34. doi:10.1093/cid/ciy657
   PubMedGoogle Scholar
• Lim C, Takahashi E, Hongsuwan M, et al. Epidemiology and burden of multidrug-resistant bacterial infection in a developing country. eLife. 2016;5. doi:10.7554/eLife.18082
   Web of Science ®Google Scholar
• MacKinnon MC, Sargeant JM, Pearl DL, et al. Evaluation of the health and healthcare system burden due to antimicrobial-resistant Escherichia coli infections in humans: a systematic review and meta-analysis. Antimicrob Resist Infect Control. 2020;9(1):200. doi:10.1186/s13756-020-00863-x
   PubMed Web of Science ®Google Scholar
• Zhu Q, Zhu M, Li C, et al. Epidemiology and microbiology of Gram-negative bloodstream infections in a tertiary-care hospital in Beijing, China: a 9-year retrospective study. Expert Rev Anti-Infect Ther. 2021;19(6):769–776. doi:10.1080/14787210.2021.1848544
   PubMedGoogle Scholar
• Linh TD, Thu NH, Shibayama K, et al. Expansion of KPC-producing Enterobacterales in four large hospitals in Hanoi, Vietnam. J Glob Antimicrob Resist. 2021;27:200–211. doi:10.1016/j.jgar.2021.09.007
   PubMedGoogle Scholar
• Stewardson AJ, Marimuthu K, SenGupta S, et al. Effect of carbapenem resistance on outcomes of bloodstream infection caused by Enterobacteriaceae in low-income and middle-income countries (PANORAMA): a multinational prospective cohort study. Lancet Infect Dis. 2019;19(6):601–610. doi:10.1016/S1473-3099(18)30792-8
   PubMed Web of Science ®Google Scholar
• Zhu Y, Xiao T, Wang Y, et al. Socioeconomic burden of bloodstream infections caused by carbapenem-resistant Enterobacteriaceae. Infect Drug Resist. 2021;14:5385–5393. doi:10.2147/IDR.S341664
   PubMed Web of Science ®Google Scholar
• Papp-Wallace KM, Endimiani A, Taracila MA, Bonomo RA. Carbapenems: past, present, and future. Antimicrob Agents Chemother. 2011;55(11):4943–4960. doi:10.1128/AAC.00296-11
   PubMed Web of Science ®Google Scholar
• Santimaleeworagun WTS, Juntanawiwat P, Thongnoy N, Harindhanavudhi S, Nakeesathit S, Teschumroon S. The prevalence of colistin-resistant Gram-negative bacteria isolated from hospitalized patients with bacteremia. J Appl Pharm Sci. 2020;10(2):056–59.
   Google Scholar
• Yamamoto M, Pop-Vicas AE. Treatment for infections with carbapenem-resistant Enterobacteriaceae: what options do we still have? Crit Care. 2014;18(3):229. doi:10.1186/cc13949
   PubMed Web of Science ®Google Scholar
• Fernandes MR, Moura Q, Sartori L, et al. Silent dissemination of colistin-resistant Escherichia coli in South America could contribute to the global spread of the mcr-1 gene. Euro Surveill. 2016;21(17):8798. doi:10.2807/1560-7917.ES.2016.21.17.30214
   Google Scholar
• Ovejero CM, Delgado-Blas JF, Calero-Caceres W, Muniesa M, Gonzalez-Zorn B. Spread of mcr-1-carrying Enterobacteriaceae in sewage water from Spain. J Antimicrob Chemother. 2017;72(4):1050–1053. doi:10.1093/jac/dkw533
   PubMed Web of Science ®Google Scholar
• Caselli E, D’Accolti M, Soffritti I, Piffanelli M, Mazzacane S. Spread of mcr-1-Driven colistin resistance on hospital surfaces, Italy. Emerg Infect Dis. 2018;24(9):1752–1753. doi:10.3201/eid2409.171386
   PubMed Web of Science ®Google Scholar
• Nguyen PTL, Tran HTM, Tran HA, et al. Carriage of plasmid-mediated colistin Resistance-1-Positive Escherichia coli in humans, animals, and environment on farms in Vietnam. Am J Trop Med Hyg. 2022;107(1):65–71. doi:10.4269/ajtmh.21-1203
   PubMedGoogle Scholar
• Ngoc VTB, Le Viet T, Nguyen Thi Tuyet M, et al. Characterization of Genetic Elements Carrying mcr-1 Gene in Escherichia coli from the Community and Hospital Settings in Vietnam. Microbiol Spectr. 2022;10(1):e0135621. doi:10.1128/spectrum.01356-21
   PubMedGoogle Scholar
• Ha VTT, Tran LD, Mai NTT, et al. Potential spread of mcr-9-carrying IncHI2 plasmids in Enterobacter hormaechei in Vietnam. J Glob Antimicrob Resist. 2021;27:332–334. doi:10.1016/j.jgar.2021.09.012
   PubMedGoogle Scholar
• Jean SS, Harnod D, Hsueh PR. Global threat of carbapenem-resistant Gram-negative bacteria. Front Cell Infect Microbiol. 2022;12:823684. doi:10.3389/fcimb.2022.823684
   PubMed Web of Science ®Google Scholar
• Birmingham MC, Rayner CR, Meagher AK, Flavin SM, Batts DH, Schentag JJ. Linezolid for the treatment of multidrug-resistant, gram-positive infections: experience from a compassionate-use program. Clin Infect Dis. 2003;36(2):159–168. doi:10.1086/345744
   PubMed Web of Science ®Google Scholar
• Kohno S, Yamaguchi K, Aikawa N, et al. Linezolid versus vancomycin for the treatment of infections caused by methicillin-resistant Staphylococcus aureus in Japan. J Antimicrob Chemother. 2007;60(6):1361–1369. doi:10.1093/jac/dkm369
   PubMed Web of Science ®Google Scholar
• WHO. Global priority list of antibiotic-resistant bacteria to guide research, discovery, and development of new antibiotics. Secondary Global priority list of antibiotic-resistant bacteria to guide research, discovery, and development of new antibiotics; 2017. Available from: https://www.who.int/news/item/27-02-2017-who-publishes-list-of-bacteria-for-which-new-antibiotics-are-urgently-needed. Accessed March 16, 2023.
   Google Scholar
• Feretzakis G, Loupelis E, Sakagianni A, et al. A 2-year single-centre audit on antibiotic resistance of Pseudomonas aeruginosa, Acinetobacter baumannii and Klebsiella pneumoniae Strains from an Intensive Care Unit and other wards in a General Public Hospital in Greece. Antibiotics. 2019;8(2):90. doi:10.3390/antibiotics8020062
   Google Scholar
• Despotovic A, Milosevic B, Milosevic I, et al. Hospital-acquired infections in the adult intensive care unit-Epidemiology, antimicrobial resistance patterns, and risk factors for acquisition and mortality. Am J Infect Control. 2020;48(10):1211–1215. doi:10.1016/j.ajic.2020.01.009
   PubMed Web of Science ®Google Scholar
• El Mekes A, Zahlane K, Ait Said L, Tadlaoui Ouafi A, Barakate M. The clinical and epidemiological risk factors of infections due to multi-drug resistant bacteria in an adult intensive care unit of University Hospital Center in Marrakesh-Morocco. J Infect Public Health. 2020;13(4):637–643. doi:10.1016/j.jiph.2019.08.012
   PubMed Web of Science ®Google Scholar